Loading...

EssilorLuxottica S.A.

EI.SWSIX
Healthcare
Medical - Specialties
CHF117.00
CHF0.00(0.00%)
Swiss Market is Open • 16:35

EI.SW News Today: Stay Updated with the Latest EssilorLuxottica S.A. News in Real Time

Find EI.SW news now at Meyka AI. Stay informed with the latest EssilorLuxottica S.A. stocks updates, including price news, market analysis, and expert insights.

ALMDT.PA stock down 1.2% ahead of April 23 earnings at €4.89
📅 20 hours ago

ALMDT.PA stock down 1.2% ahead of April 23 earnings at €4.89

ALMDT.PA stock trades at €4.89 with -1.2% decline. Median Technologies reports earnings April 23. Meyka AI rates stock B with Hold recommendation.

Read more
Sanofi (SAN.PA) Gains 1.46% Ahead of Q1 2026 Earnings on April 23
📅 1 day ago

Sanofi (SAN.PA) Gains 1.46% Ahead of Q1 2026 Earnings on April 23

SAN.PA stock rises 1.46% to €82.03 on EURONEXT as Sanofi prepares Q1 2026 earnings announcement April 23. Healthcare sector analysis.

Read more
GV.PA Stock Surges 5.88% on April 14: Genomic Vision SA Trading Activity Peaks
📅 8 days ago

GV.PA Stock Surges 5.88% on April 14: Genomic Vision SA Trading Activity Peaks

GV.PA stock rises 5.88% intraday on EURONEXT. Genomic Vision SA shows elevated trading volume of 38.49M shares amid healthcare sector volatility.

Read more
Meta Glasses Delayed in EU Due to Battery Regulations and Supply Issues
📅 28 days ago

Meta Glasses Delayed in EU Due to Battery Regulations and Supply Issues

The global rollout of Meta Glasses has faced an unexpected slowdown in Europe after regulatory challenges and supply shortages forced the company to delay its launch plans. The development highlights how technology innovation increasingly depends on compliance with regional laws, especially in markets with strict consumer protection and environmental rules. Investors, technology watchers, and stock…

Read more
EssilorLuxottica: Analyzing Current Stock Performance Amidst Market Challenges
📅 4 months ago

EssilorLuxottica: Analyzing Current Stock Performance Amidst Market Challenges

Explore EssilorLuxottica’s stock performance on Euronext, including financials, technical indicators, and future forecasts. A look into healthcare and

Read more
Costco Suing Trump: Retail Giant Challenges Emergency Tariff Orders
📅 5 months ago

Costco Suing Trump: Retail Giant Challenges Emergency Tariff Orders

Costco Suing Trump – What’s the Case About Costco, one of the largest retailers in America and globally, has formally filed a lawsuit against the Trump administration. The company asks a U.S. trade court to guarantee it will receive a full refund if the Supreme Court invalidates the president’s sweeping emergency tariff orders imposed under…

Read more
META Labs Q3 Earnings: Heavy Metaverse Spending Drives $4.4B Loss for Reality Labs
📅 6 months ago

META Labs Q3 Earnings: Heavy Metaverse Spending Drives $4.4B Loss for Reality Labs

We’ve just seen the latest results from Meta Platforms, Inc. (ticker: META) for their third quarter, and the story is both strong and startling. The company reported $51.24 billion in revenue, up about 26% compared to a year ago. But behind that growth lurks a big number: its metaverse‑focused division, Reality Labs, lost roughly $4.4 billion in…

Read more
EssilorLuxottica Today: Stock Soars as Meta Partnership Lifts Q3 Earnings
📅 6 months ago

EssilorLuxottica Today: Stock Soars as Meta Partnership Lifts Q3 Earnings

On October 17, 2025, EssilorLuxottica stunned the markets. Its stock jumped after the company announced record third-quarter results. The surge came largely because of its partnership with Meta Platforms, which has given new life to smart eyewear. EssilorLuxottica is best known for brands like Ray-Ban and Oakley. But now it is also a tech innovator….

Read more
EssilorLuxottica’s Strategic Move: Increasing Stake in Nikon Corporation
📅 8 months ago

EssilorLuxottica’s Strategic Move: Increasing Stake in Nikon Corporation

EssilorLuxottica plans to increase its stake in Nikon from 9% to 20%, aiming to enhance its strategic position in the optical industry.

Read more

EI.SW News FAQ